Skip to content
value.today

LineaGen Inc

🇺🇸 Salt Lake City, Utah, USAHealth CareFounded 2006
Total raised
$45 M
4 rounds on record
Latest round
$12 M
Jan 2015
First round on record
May 2010
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of LineaGen Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Jan 2015$12 MNo. 4$10 to $50 million

LineaGen Inc: Raise no. 4, Jan 2015

Investors in this round

10 investors had bought by the notice of Jan 26, 2015: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$12 M of $12 M offered
Smallest investment taken
no minimum stated
What was sold
equity, other: Shares of Series C-1 Preferred Stock and the underlying shares of Common Stock issuable upon conversion thereof
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gayland C. Moffat · Executive Officer
  • Michael S. Paul · Executive Officer, Director
  • David C. Kabakoff · Director
  • Fred A. Middleton · Director
  • Lisa A. Dunlea · Director
  • Mary C. Tanner · Director
  • Michael A. Fitzgerald · Director
  • Michael A. Walsh · Director
  • Stephen M. Prescott · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Frederick Dorey, Assistant Secretary. Source: SEC Form D, newest notice filed Jan 26, 2015. Read the notice at the SEC.

equitySEC
Nov 2013$16 MNo. 3$10 to $50 million

LineaGen Inc: Raise no. 3, Nov 2013

Investors in this round

21 investors had bought by the notice of Nov 25, 2013: 21 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$16 M of $24 M offered; $7 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Shares of Series B Preferred Stock and Series C Preferred Stock and the underlying shares of Common Stock issuable upon conversion thereof
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gayland C. Moffat · Executive Officer
  • Michael S. Paul · Executive Officer, Director
  • Daniel C. Wood · Director
  • Fred A. Middleton · Director
  • Lisa A. Dunlea · Director
  • Mary C. Tanner · Director
  • Michael M. Jerstad · Director
  • Stephen M. Prescott · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Frederick Dorey, Assistant Secretary. Source: SEC Form D, newest notice filed Nov 25, 2013. Read the notice at the SEC.

equitySEC
Dec 2010$12 MNo. 2$10 to $50 million

LineaGen Inc: Raise no. 2, Dec 2010

Investors in this round

16 investors had bought by the notice of Apr 25, 2013: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$12 M of $25 M offered; $13 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt, options or other rights to buy securities, securities to be acquired by exercising them, other: Convertible promissory notes and warrants,the underlying shares of Equity Securities issuable upon conversion of the notes and exercise of warrants and the underlying shares of common stock issuable u
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
$83,500
Finders' fees
$8,132
Paid to its own people
$1,015,647 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks finders' fees and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gayland K. Moffat · Executive Officer
  • Michael S. Paul · Executive Officer, Director
  • Daniel C. Wood · Director
  • Dinesh A. Patel · Director
  • Fred A. Middleton · Director
  • Mary C. Tanner · Director
  • Michael M. Jerstad · Director
  • Stephen M. Prescott · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Bendigo Securities, LLC (CRD 152529) · New York, New YorkSold in NY
  • Pharus Securities, LLC (CRD 148002) · broker-dealer MIchael Goodman (CRD 5582359) · New York, New YorkSold in CA, CO, CT, IL, MA, MD, NY, PA, TX, UT

Remarks in the notice

  • On fees: “Of the $91,631.76 paid, $82,000 was for fees, $1500 for a retainer for future sales, and the balance of approximately $8,131.76 was for reimbursement of expenses”
  • On the use of proceeds: “Consists of approximate amount of ordinary compensation paid or expected to be paid to officers since December 2010 and payable through 2013, and $17,500 in consulting fees payable to a director”

Signed by Michael S. Paul, President & CEO. Source: SEC Form D and 4 amendments, newest notice filed Apr 25, 2013. Read the notice at the SEC.

equity, debt, optionsSEC
May 2010$5 MNo. 1$2 to $10 million

LineaGen Inc: Raise no. 1, May 2010

Investors in this round

9 investors had bought by the notice of Jun 23, 2010: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Marc S. White · Executive Officer
  • Michael S. Paul · Executive Officer, Director
  • Al S. Harris · Director
  • Daniel C. Wood · Director
  • Dinesh A. Patel · Director
  • Fred A. Middleton · Director
  • Michael M. Jerstad · Director
  • Stephen M. Prescott · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael S. Paul, President & CEO. Source: SEC Form D, newest notice filed Jun 23, 2010. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • LineaGen Inc chose not to state its revenue in its newest notice of a funding round (Jan 2015).

    SEC Form D · Jan 2015

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jan 2015

That is all the official record says: LineaGen Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of LineaGen Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 21 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by LineaGen Inc
NameRoleNamed in
Gayland C. MoffatExecutive officerJan 2015
Michael S. PaulExecutive officerJan 2015
Gayland K. MoffatExecutive officerApr 2013
Burt K. De MillExecutive officerApr 2013
Marc S. WhiteExecutive officerJun 2010
David C. KabakoffDirectorJan 2015
Fred A. MiddletonDirectorJan 2015
Lisa A. DunleaDirectorJan 2015
Mary C. TannerDirectorJan 2015
Michael A. FitzgeraldDirectorJan 2015
Michael A. WalshDirectorJan 2015
Michael S. PaulDirectorJan 2015
Stephen M. PrescottDirectorJan 2015
Daniel C. WoodDirectorNov 2013
Michael M. JerstadDirectorNov 2013
Dinesh A. PatelDirectorApr 2013
Al M. HarrisDirectorJun 2012
Al S. HarrisDirectorJun 2010